ICU MEDICAL INC/DE - 8-K Filing
ICU Medical reported first-quarter 2026 GAAP revenue of $530.2 million, a 12% decline year-over-year, primarily due to the May 2025 divestiture of its IV Solutions business. GAAP gross margin improved to 39% from 35% in the prior year. GAAP net income was $30.1 million, or $1.20 per diluted share, compared to a $15.5 million loss in the first quarter of 2025. Adjusted diluted earnings per share were $1.97, up from $1.72 in the prior-year period. (Items: 2.02 Results of Operations and Financial Condition On May 7, 2026, ICU Medical, Inc, 9.01 Financial Statements and Exhibits)
Tickers: $ICUI